Arcus Biosciences Inc (RCUS) financials
Arcus Biosciences revenue and earnings by year
Arcus Biosciences's revenue was $247 million in the fiscal year to December 31, 2025, down 4.3% from the year before. Net income was -$353 million, -142.9% of revenue. Since the fiscal year to December 31, 2017, revenue has grown 90.7% a year on average.
Fiscal years, each labelled by the calendar year it ended in.
Income statement, the last 9 fiscal years
| Fiscal year to | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 247 | 258 | 117 | 112 | 383 | 78 | 15 | 8 | 1 |
| Revenue growth | -4.3% | 120.5% | 4.5% | -70.8% | 391.0% | 420.0% | 79.6% | 491.2% | — |
| Operating income | -386 | -330 | -340 | -280 | 54 | -124 | -89 | -55 | -53 |
| Operating margin | -156.3% | -127.9% | -290.6% | -250.0% | 14.1% | -159.0% | -591.4% | -656.8% | -3782.1% |
| Net income | -353 | -283 | -307 | -267 | 53 | -123 | -85 | -50 | -53 |
| Net margin | -142.9% | -109.7% | -262.4% | -238.4% | 13.8% | -157.7% | -564.7% | -593.7% | -3756.7% |
| Diluted EPS | -$3.29 | -$3.14 | -$4.15 | -$3.71 | $0.71 | -$2.34 | -$1.93 | — | -$28.02 |
| Free cash flow | -484 | -176 | -330 | 432 | -282 | 108 | -75 | -47 | -31 |
Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open RCUS in Markets.
How Arcus Biosciences makes money
Revenue by segment in the quarter to June 30, 2026, as the company reports it.
| Segment | Revenue | Share |
|---|---|---|
| Other Collaboration Revenue | $25.0M | 61.0% |
| License & Development Services | $16.0M | 39.0% |
See also: RCUS returns
No forecast, no recommendation. This page describes Arcus Biosciences Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.